Legislation currently under consideration in the U.S. Congress would increase regulatory oversight of certain diagnostic tests, and a new study by researchers at Massachusetts General Hospital (MGH) and colleagues from […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) PEER REVIEWED Holly Bookless, BSN, RN, NE-BC; Paula Smailes, DNP, RN, CCRP; Todd Lusch, BA; Deanna Golden-Kreutz, PhD What was originally known […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) PEER REVIEWED Christina Morris; Erika Stevens, MA Biotechnology, medical device, and pharmaceutical companies are seeking other industries’ disruptive digital technologies to aid […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) GOOD MANAGEMENT PRACTICE Scott Gray It's no secret that patient diversity is a major issue in clinical trials, and that a lack […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) SITES & SPONSORS Mark Clements, MD, PhD, CPI, FAAP; Komathi Stem, MS COVID-19’s effect on clinical trials is a tale of two […]